Skip to main content

Immunic, Inc.

IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001280776

No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Immunic, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of IMUX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders5661+5
Shares50.2M42.7M−7.49M (−14.9%)
Value$35.0M$37.6M+$2.63M (+7.5%)

New holders (14)

Institutions that held Immunic, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to IMUX in Q3 2025
InstitutionSharesValue% of portfolio
Citadel Advisors LLC535,083$471.7K0.00%
Squarepoint Ops LLC271,574$239.4K0.00%
Jane Street Group, LLC195,331$172.2K0.00%
Gsa Capital Partners LLP192,923$170.0K0.01%
Exome Asset Management LLC173,900$153.3K0.10%
Virtu Financial LLC112,287$99.0K0.01%
HB Wealth Management, LLC91,450$80.6K0.00%
Two Sigma Investments, LP58,681$51.7K0.00%
LPL Financial LLC53,050$46.8K0.00%
Qube Research & Technologies Ltd32,669$28.8K0.00%
Wolverine Trading, LLC10,953$10.2K0.00%
Rockefeller Capital Management L.P.1,000$8820.00%
Allworth Financial LP842$7430.00%
Bell Investment Advisors, Inc649$5730.00%

Sold out (9)

Institutions that held Immunic, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of IMUX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Omega Fund Management, LLC1,788,160$1.25M
Ghisallo Capital Management LLC835,000$582.4K
RTW Investments, LP402,107$280.5K
Group One Trading, L.P.75,899$52.9K
683 Capital Management, LLC62,458$43.6K
UBS Oconnor LLC30,000$20.9K
Dimensional Fund Advisors LP13,151$9.17K
Raymond James Financial Inc2,025$1.41K
Tower Research Capital LLC (TRC)2,007$1.40K